Rajesh K. Malik
Chief Tech/Sci/R&D Officer chez G1 THERAPEUTICS, INC.
Fortune : 734 132 $ au 31/03/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Stephen V. Frye | M | - |
Meryx, Inc.
 Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC. | 17 ans |
| Jack Bailey | M | 59 | 4 ans | |
| Norman Sharpless | M | 57 | 10 ans | |
| Garry Nicholson | M | 69 | 6 ans | |
| Monica Thomas | F | - | 1 ans | |
| Glenn Muir | M | 65 | 9 ans | |
| Michael Thompson | M | - | 1 ans | |
| Jacks Lee | M | - | 2 ans | |
| H. Shelton Earp | M | - |
Meryx, Inc.
Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC. | 17 ans |
| Douglas K. Graham | M | - |
Meryx, Inc.
Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC. | 17 ans |
| Terry Murdock | M | 64 | 7 ans | |
| Alicia Secor | F | 62 | 3 ans | |
| Philip Johnson | M | 59 | 1 ans | |
| Sailash I. Patel | M | - |
Meryx, Inc.
Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC. | - |
| Cynthia Flowers | F | 64 | 6 ans | |
| William C. Roberts | M | 54 | 3 ans | |
| Andrew Beelen | M | - | - | |
| John Umstead | M | - | 6 ans | |
| Mark Avagliano | M | 48 | 5 ans | |
| Gordon Brooks | M | - | 1 ans | |
| Andrew Perry | M | 51 | 3 ans | |
| Chris Anderson | M | - | 1 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 97 | 97,00% |
| Allemagne | 3 | 3,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Rajesh K. Malik
- Réseau Personnel
